THIOGUANINE Drug Patent Profile
✉ Email this page to a colleague
When do Thioguanine patents expire, and what generic alternatives are available?
Thioguanine is a drug marketed by Waylis Therap and is included in one NDA.
The generic ingredient in THIOGUANINE is thioguanine. Three suppliers are listed for this compound. Additional details are available on the thioguanine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Thioguanine
A generic version of THIOGUANINE was approved as thioguanine by WAYLIS THERAP on December 31st, 1969.
Summary for THIOGUANINE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 171 |
Clinical Trials: | 91 |
Patent Applications: | 8,593 |
Formulation / Manufacturing: | see details |
DailyMed Link: | THIOGUANINE at DailyMed |
Recent Clinical Trials for THIOGUANINE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
St George's University of London, London, UK | Phase 2 |
Sanjay Gandhi Postgraduate Institute of Medical Sciences | Phase 2 |
Incyte Corporation | Phase 1 |
Pharmacology for THIOGUANINE
Drug Class | Antimetabolite |
Medical Subject Heading (MeSH) Categories for THIOGUANINE
US Patents and Regulatory Information for THIOGUANINE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Waylis Therap | THIOGUANINE | thioguanine | TABLET;ORAL | 012429-001 | Approved Prior to Jan 1, 1982 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |